The Gold Trade, May 24
Health Care: Drugs
Medicines (MDCO: NASDAQ)
$32.99 -0.33 | -0.99%
05/24/13 - 04:00 PM ET
756.27K / 878.80K
Vol / Avg. Vol:33.04 / 33.32
Open / Prev. Close:32.51 - 33.35
Today's Range:20.04 - 37.40
52 Wk Range:39.01%
Performance YTD:TheStreet Rating:
Portfolios with MDCO
- Portfolio NameUser Type
- ContributorStocks Rising On Unusual Vo...
- UserGFNN Stockdiagnostics 3
- ContributorStocks At New 52-Week Highs...
- ContributorBreakout Stocks Of The Week...
- UserSUPRATRADE Top 10 Small Cap...
- Userdarrylb Portfolio 1
- Usermiamirocksters Portfolio 1
- ContributorBarron's Research Reports 4...
- UserPART 3 JPMorgan 27th Annual...
- UserNurse Nymph looks for Medic...
Latest MDCO Headlines from TheStreet
- 4 Big Stocks Rising on Big Volume 03.11.13 | 02:03 pm
- J&J Taps Bayer Exec For New Post Over 3 Divisions 09.13.12 | 09:09 am
- Business Highlights 08.20.12 | 06:08 pm
- J&J 2Q Profit Down By Half On Lower Sales, Charges 07.17.12 | 05:07 pm
- New J&J CEO To Discuss $20B Purchase In 2Q Report 07.13.12 | 02:07 pm
- News Summary: J&J In Tentative Deal On Lawsuit 07.12.12 | 08:07 pm
- J&J, Shareholders Reach Tentative Deal In Lawsuit 07.12.12 | 06:07 pm
- Medicines Reaches New 52-Week High (MDCO) 06.05.12 | 02:06 pm
- Medicines (MDCO): Today's Featured Health Care Winner 05.17.12 | 05:05 pm
- The Medicines' CEO Presents At Deutsche Bank Annual Healthcare Conference (Transcript) 05.07.12 | 06:05 pm
Press Releases for MDCO
- The Medicines Company And Alnylam Form Strategic Alliance To Develop And Commercialize RNAi Therapeutics Targeting PCSK9 For The Treatment Of Hypercholesterolemia - Business Wire 02.04.13 | 06:02 am
- AstraZeneca And The Medicines Company Announce Global Collaboration In Acute Ischemic Heart Disease - Business Wire 04.25.12 | 12:04 pm
- Boston Scientific Supports New Clinical Trial To Evaluate Platinum Chromium Coronary Stents In Treating Heart Attack Patients - PR Newswire 03.26.12 | 08:03 am
- Ligand And The Medicines Company Agree To Worldwide License For Proprietary Captisol®-Enabled Intravenous Formulation Of Clopidogrel - Business Wire 06.03.11 | 09:06 am
Partner Headlines for MDCO
- Stocks' Losses Mount After Lousy Manufacturing Data - Investor's Business Daily 04.18.13 | 03:04 pm
- Alkermes Leaps On Study Results, May Offer New Entry - Investor's Business Daily 04.17.13 | 05:04 pm
- Blood Clots Are Big Market For Biotech Medicines Co. - Investor's Business Daily 04.16.13 | 05:04 pm
- Futures Cut Losses, Gold Tanks; Sprint Nextel Up On Dish Offer - Investor's Business Daily 04.15.13 | 08:04 am
- Stock Leaders' Wobbles Reflect The Broad Market - Investor's Business Daily 04.12.13 | 06:04 pm
- You Can Still Find Buyable Leaders In Stock Market - Investor's Business Daily 03.22.13 | 06:03 pm
- Here's What To Look For In A 'Going Nowhere' Market - Investor's Business Daily 03.22.13 | 05:03 pm
- Stocks Mixed Near Midday; MagnaChip Leads IBD 50 List - Investor's Business Daily 03.19.13 | 12:03 pm
- Biotech Watch-List: Medicine Co., Alkermes, Celgene - Investor's Business Daily 03.11.13 | 05:03 pm
- Stocks Trim Morning Losses; Medicines Co. Up On Trial Data - Investor's Business Daily 03.11.13 | 12:03 pm
